Group Company

About Stemgent

About Stemgent

Cutting-edge research reagent provider for iPS cell from America

Efficiently and safely creates iPS cell with a clinical application through mRNA Reprogramming, which is cutting-edge technology

Also, has the technology of more efficient and high-quality differentiation with the specialty chemical technology

Company profile

Corporate name Stemgent, Inc.
Location Cambridge, MA, USA
Representative Joseph Gentile
Business lineup Manufacture and sale of research reagents for iPS Cell

About BioServe

About BioServe

One of the largest commercial human tissue banks in the world

Stocked with more than 600,000 human tissue, serum, DNA, and RNA samples, from over 120,000 patients and over 700 affiliated medical institutions all over the world

(Global BioRepository inventory by disease)
Cancer, Metabolic, Immunological Disorders, etc.

Company profile

Corporate name BioServe Biotechnologies, Ltd.
Location Beltsville, MD, USA
Representative Rama Modali
Business lineup Human tissue repository and provision

About Reinnervate

About Reinnervate

Leads rapidly growing 3D culture market

Capable of culturing in near-vivo environment and ideal conditions more than 2D cell culture
Receive much attention as a new technology in the realms of iPS cell and regenerative medicine

Company profile

Corporate name Reinnervate Limited
Location Co. Durham, UK
Representative Daisuke Usui
Business lineup Development, production and sale of 3D culture device

About Biopta

Biopta

Biopta provides unique assay services employing fresh human tissues to support drug development

By providing contract research services to the pharmaceutical industry since 2002, Biopta has become a world leader in the use of fresh functional human tissues to better predict drug activity prior to clinical trials. Drug development risk can be minimized by predicting the safety, efficacy, absorption or metabolism of compounds in phenotypically-relevant healthy and diseased human tissues. With expertise in all areas of human tissues research including sourcing, handling and experimentation, Biopta scientists are on-hand 24/7 to work on any project as soon as fresh tissues arrives. The experienced Biopta team assists pharmaceutical researchers with protocol design and technology platform selection to ensure that data collection and results are high quality and trustworthy. And by guaranteeing strict adherence to ethical guidelines, legal requirements and GLP laboratory practices, Biopta has emerged as a trusted partner of leading pharmaceutical companies worldwide.

Company profile

Corporate name Biopta Limited
Location Glasgow, UK
Representative David Bunton
Business lineup Sourcing, handling, experimentation with fresh human tissues for drug development research